PRESIDENT HAS SERVED AS A REVIEWER FOR THE ZRG1 BST-H (50) PAR-16-390 ‘NIBIB Trailblazer Award for New and Early Stage Investigators’ (R21) STUDY SECTION FOR THE NIH

PDX Pharma’s President has served as a reviewer for the ZRG1 BST-H (50) PAR-16-390 ‘NIBIB Trailblazer Award for New and Early Stage Investigators’ (R21) Study Section for the National Institute of Health (NIH) held on June 28, 2017.

pdx news

  • siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion

    10/9/2019
    read more

  • PRESIDENT SERVES ON SCIENTIFIC REVIEW PANELS FOR THE DOD AND NIH IN NOVEMBER OF 2019

    10/9/2019
    read more

  • PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer published in Cancer Letters

    10/9/2019
    read more

Copyright © 2017 PDX Pharmaceuticals, LLC. All rights reserved